1 刘 熙, 李 琦. 我国成人社区获得性肺炎诊疗现状及思考[J/CD]. 中华肺部疾病杂志(电子版), 2021, 14(3): 387-389.
2 徐 丹, 殷 明, 余 苗, 等. 社区获得性肺炎外周血miR-182及miR-126的表达及临床意义[J/CD]. 中华肺部疾病杂志(电子版), 2022, 15(2): 197-199.
3 Restrepo MI, Mortensen EM, Velez JA, et al. A comparative study of community-acquired pneumonia patients admitted to the ward and the ICU[J]. Chest, 2008, 133(3): 610-617.
4 Leoni D, Rello J. Severe community-acquired pneumonia: optimal management[J]. Curr Opin Infect Dis, 2017, 30(2): 240-247.
5 Rello J, Rodriguez R, Jubert P, et al. Severe community-acquired pneumonia in the elderly: epidemiology and prognosis. Study group for severe community-acquired pneumonia[J]. Clin Infect Dis, 1996, 23(4): 723-728.
6 Miyashita N, Yamauchi Y. Bacterial pneumonia in elderly Japanese populations[J]. Jpn Clin Med, 2018, 9: 1179670717751433.
7 Huang Y, Liu A, Liang L, et al. Diagnostic value of blood parameters for community-acquired pneumonia[J]. Int Immunopharmacol, 2018, 64: 10-15.
8 Christ-Crain M, Muller B. Biomarkers in respiratory tract infections: diagnostic guides to antibiotic prescription, prognostic markers and mediators[J]. Eur Respir J, 2007, 30(3): 556-573.
9 Kopterides P, Siempos I, Tsangaris I, et al. Procalcitonin-guided of antibiotic therapy in the intensive care unit: A systematic review and Meta-analysis of randomized controlled trials[J]. Criti Care Med, 2010, 38(11): 2229-2241.
10 Karakioulaki M, Stolz D. Biomarkers in pneumonia-beyond procalcitonin [J]. Int J Mol Sci, 2019, 20(8): 2004. 10.3390 /ijms20082004.
11 Lim WS, van der Eerden MM, Laing R, et al. Defining community acquired pneumonia severity on presentation to hospital: an international derivation and validation study[J]. Thorax, 2003, 58: 377-382.
12 Zahorec R. Ratio of neutrophil to lymphocyte counts-rapid and simple parameter of systemic inflammation and stress in critically ill[J]. Bratislavské Lekárske Listy, 2001, 102(1): 5-14.
13 焦桂微, 王新婷, 任 强, 等. NLR在COPD合并CAP与AECOPD患者中诊断与预后的意义[J/CD]. 中华肺部疾病杂志(电子版), 2022, 15(1): 20-23.
14 中华医学会呼吸病学分会. 中国成人社区获得性肺炎诊断和治疗指南(2016年版)[J].中华结核和呼吸杂志, 2016, 39(4): 253-279.
15 Chen L, Zhou F, Li H, et al. Disease characteristics and management of hospitalised adolescents and adults with community-acquired pneumonia in China: a retrospective multicentre survey[J]. BMJ Open, 2018, 8(2): e018709.
16 Ietomi K. A study on the role of granulocytes in carcinoma-bearing hosts-G/L ratio as a new host indicator[J]. Nippon Gan Chiryo Gakkai shi, 1990, 25(3): 662-671.
17 Wyllie HD. Relation between lymphopenia and bacteraemia in UK adults with medical emergencies[J]. J Clin Pathology, 2004, 57(9): 950-955.
18 Unsinger J, Kazama H, Mcdonough JS, et al. Differential lymphopenia-induced homeostatic proliferation for CD4+ and CD8+ T cells following septic injury[J]. J Leukoc Biol, 2009, 85(3): 382-390.
19 Fantin B, Joly V, Elbim C, et al. Lymphocyte subset counts during the course of community-acquired pneumonia: evolution according to age, human immunodeficiency virus status, and etiologic microorganisms[J]. Clin Infect Dis, 1996, 22(6): 1096.
20 Alzoubi O, Khanfar A. Association between neutrophil to lymphocyte ratio and mortality among community acquired pneumonia patients: a meta-analysis[J]. Monaldi Arch Chest Dis, 10.4081/monaldi.2021.2050
21 Prucha M, Bellingan G, Zazula R. Sepsis biomarkers[J]. Clin Chim Acta, 2015, 440, 97-103.
22 Meisner M. Update on procalcitonin measurements[J]. Ann Lab Med, 2014, 34(4): 263-273.
23 El-Solh AA, Vora H, Knight PR 3rd, et al. Diagnostic use of serum procalcitonin levels in pulmonary aspiration syndromes[J]. Crit Care Med, 2011, 39(6): 1251-1256.
24 Tang BM, Eslick GD, Craig JC, et al. Accuracy of procalcitonin for sepsis diagnosis in critically ill patients: systematic review and meta-analysis[J]. Lancet Infect Dis, 2007, 7(3): 210-217.
25 Gilbert DN. Procalcitonin and pulmonary aspiration: another possible interpretation[J].Crit Care Med, 2011, 39(8): 2019- 2020.
26 Hunziker S, Hugle T, Schuchardt K, et al. The value of serum procalcitonin level for differentiation of infectious from noninfectious causes of fever after orthopaedic surgery[J]. Bone Joint Surg, 2010, 92(1): 138-148.
27 Lim WS, Eerden MMVD, Laing R, et al. Defining community acquired pneumonia severity on presentation to hospital: an international derivation and validation study[J]. Thorax, 2003, 58(5): 377-382.
28 马文通, 张 泓. CURB-65评分和强化CURB评分对老年重症社区获得性肺炎预测价值的临床研究[J]. 中国急救医学, 2016, 36(3): 238-241.
29 王 震, 史金英, 宋 宁. 中性粒细胞/淋巴细胞比值对社区获得性肺炎严重程度的评估价值[J]. 河北医药, 2015,(8): 1211-1212.
30 宋 维, 潘萌萌, 韩铭欣, 等. NLR和PCT对成人社区获得性肺炎患者进展为脓毒症的预测价值比较[J]. 疑难病杂志, 2020, 19(2): 118-121.